It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The development and function of the brain require tight control of gene expression. Genome architecture is thought to play a critical regulatory role in gene expression, but the mechanisms governing genome architecture in the brain in vivo remain poorly understood. Here, we report that conditional knockout of the chromatin remodeling enzyme Chd4 in granule neurons of the mouse cerebellum increases accessibility of gene regulatory sites genome-wide in vivo. Conditional knockout of Chd4 promotes recruitment of the architectural protein complex cohesin preferentially to gene enhancers in granule neurons in vivo. Importantly, in vivo profiling of genome architecture reveals that conditional knockout of Chd4 strengthens interactions among developmentally repressed contact domains as well as genomic loops in a manner that tightly correlates with increased accessibility, enhancer activity, and cohesin occupancy at these sites. Collectively, our findings define a role for chromatin remodeling in the control of genome architecture organization in the mammalian brain.
The mechanisms underlying gene regulation and genome architecture remain poorly understood. Here, the authors investigate the role of chromatin remodelling enzyme Chd4 in granule neurons of the mouse cerebellum and find that conditional knockout of Chd4 preferentially activates enhancers and modulates genome architecture at a genome-wide level.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Washington University School of Medicine, Department of Neuroscience, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); Washington University School of Medicine, Medical Scientist Training Program, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
2 Washington University School of Medicine, Department of Neuroscience, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); University of Tsukuba, Faculty of Medicine, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); Northwestern University, Department of Neurobiology, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
3 Washington University School of Medicine, Department of Neuroscience, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); Northwestern University, Department of Neurobiology, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
4 Washington University School of Medicine, Department of Neuroscience, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)